Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells is a research paper published in Diagnostics (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: #P30CA177558
National Institutes of Health
Grant: 3P30CA177558-01S1
CTRP Supplement
FWCI
2.51
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals